Medtech Talk

194 Folgen

1. Perfecting the Fast-Follower Strategy – How Blue Belt Built and Sold a Successful Robotics Business

   Vom: 14.7.2016
2. How Do You Build a Start-Up into a $600 Million Exit? We Ask Matt Likens, Former CEO of Ulthera

   Vom: 7.7.2016
3. Gilde Healthcare’s Geoff Pardo on Why European LPs & VCs See Opportunity in the US Medtech Market

   Vom: 30.6.2016
4. Allen Partners’ Julie Allen on How New Leaders Can Find Success in Today’s Evolving Medtech Sector

   Vom: 23.6.2016
5. Sounds from the Stage: Hear "What it Takes to Win in Medtech" from Four Successful CEOs

   Vom: 16.6.2016
6. Medtronic’s Martha Discusses Fear, Transformation & Acquisitions

   Vom: 9.6.2016
7. Where are we in the Robotics Revolution?

   Vom: 3.6.2016
8. How Vascular Solutions Beat the DOJ & What Medtech Executives Need to Know to Do the Same

   Vom: 26.5.2016
9. MDMA’s Leahey Updates on Device Tax, Reimbursement & What the White House Says About Medtech

   Vom: 19.5.2016
10. Facteau Looks Forward to Day in Court & Eyes Funding for Earlens

    Vom: 15.5.2016
11. How Will Abbott & Auris Deals Impact Early Stage Start-ups?

    Vom: 3.5.2016
12. Newly Minted VC Stacy Enxing Seng Talks Medtech, Medtronic & Why She Joined Lightstone

    Vom: 28.4.2016
13. Thom Gunderson Offers Insights on Innovation, IPOs, and Google from a Long-time Medtech Market Watcher

    Vom: 21.4.2016
14. Windham’s Yee on Why She Thinks Medtech’s Renaissance is Drawing Future New Leaders

    Vom: 14.4.2016
15. Design Firm Nottingham Spirk has Grand Plans to Bolster Medtech Start-ups

    Vom: 7.4.2016
16. HealthQuest’s Kong on teamwork, Medtech, and investing $225 million

    Vom: 30.3.2016
17. How Kerry Pope and the Fogarty Institute Keep Medtech Innovation Alive

    Vom: 23.3.2016
18. Trigg: Outset’s Tablo Could Create `Boutique’ Dialysis

    Vom: 15.3.2016
19. Hykes Recounts Successful Outcomes from Visiogen, Cameron

    Vom: 8.3.2016
20. Justin Klein, MD, JD, Partner at New Enterprise Associates

    Vom: 29.2.2016